Valuation (59%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 35.54 | 30.29 |
| PEG Ratio (TTM) | 0.33 | -0.29 |
| P/S Ratio (TTM) | 0.99 | 3.55 |
| P/B Ratio (TTM) | 1.45 | 31.78 |
| P/FCF Ratio (TTM) | 25.60 | 24.81 |
| Price to 5YR AVG Earnings Ratio | -68.89 | 26.61 |
| Price to 5YR AVG FCF Ratio | 26.41 | 24.43 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.36% | 10.83% |
| ROE (TTM) | 4.08% | 118.76% |
| Net Profit Margin (TTM) | 2.78% | 13.03% |
| ROIC 5YR AVG | 3.04% | 26.41% |
Growth (77%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 1,903.55% | 208.64% | 124.44% |
| Revenue | 1.61% | -10.92% | -3.58% |
| Net Income | 2,160.98% | 215.87% | 132.21% |
| Cash Flow | 32.08% | 248.72% | 146.10% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.85 | 0.91 |
| Quick Ratio (TTM) | 0.55 | 0.64 |
| D/E Ratio (TTM) | 0.94 | 3.87 |
| Interest Coverage (TTM) | 2.40 | 15.03 |
| Piotroski F-Score | 8 | 8 |
| Altman Z-Score | 0.50 | 5.30 |
| LTL to 5YR AVG FCF | 17.63 | 4.38 |
| Shares Outstanding Growth 5YR AVG | 3.11% | -0.20% |